Precision medicine is an emerging medical approach undertaken by medical practitioners for the treatment of a patient, followed with medical decisions, treatments, practices, or products being tailored to the individual patient. Appropriate or optimal therapies may be employed based on variability in the patients genetic profile, environment, and lifestyle for each person.

According to a new report published by Allied Market Research, titled, Precision Medicine Software Marketby Delivery Mode (On-premise and Cloud-based), Application (Oncology, Pharmacogenomics, Rare Diseases, and Others), and End User (Healthcare Providers, Research Centers & Government Institutes, and Pharmaceutical & Biotechnology Companies): Global Opportunity Analysis and Industry Forecast, 2019-2026

The diagnostic testing can be based on the context of an individuals genetic profile or other molecular or cellular analysis. The emergence of precision medicine has addressed the dire need for better diagnostic and analytical tools. Precision medicine software combines the clinical and molecular data to provide with valuable insights to determine the ideal therapeutic course of treatment.

Download Report Sample @https://www.alliedmarketresearch.com/request-sample/5675

The global market size of Precision Medicine Software Market is $XX million in 2018 with XX CAGR, and it is expected to reach $XX million by the end of 2026 with a CAGR of XX% from 2019 to 2026.

Global Precision Medicine Software Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.

The precision medicine software market is segmented on the basis of delivery mode, end user, application, and region.

Based on delivery mode, the precision medicine software market is classified into on-premise and cloud-based systems.

Depending on end-user, it is categorized into healthcare providers, research centers & government institutes, and pharmaceutical & biotechnology companies.

By application, it is segregated into oncology, pharmacogenomics, rare diseases, and others.

Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

For Purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/5675

The Major Key Players Are:

Synapse, Inc., Allscripts Healthcare Solutions, Inc. (2bPrecise LLC), Roche Holdings, Inc. (Foundation Medicine, Inc.), Fabric Genomics, Inc., Sophia Genetics SA, PierianDx, Inc., Qiagen N.V. (N-of-One, Inc.), Human Longevity, Inc., Roper Technologies, Inc. (Sunquest Information Systems, Inc.), Gene42, Inc. Other players in the value chain include Translational Software, Inc., LifeOmic Health, LLC, NantHealth, Inc., Tempus Labs, Inc., Flatiron Health, Inc., IBM Watson Group, and Koninklijke Philips N.V.

Contact:

David CorreaPortland, OR, United StatesUSA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1(855)550-5975help@alliedmarketresearch.comWeb:https://www.alliedmarketresearch.comFollow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

See more here:
Impact of COVID-19 on Precision Medicine Software Market to Significant Growth, In-depth Analysis, Future Trends and Forecast 2026 - WOLE TV